drugset
drugset / Trial / NCT04660773

PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY UREAMIC PRURITIS

NCT04660773 ↗

Phase 2 Unknown 40 enrolled Alexandria University
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients will be randomly assigned into 2 groups: 1. Group A: (20 patients) will receive NB UVB phototherapy 3 sessions per week for 2 months. 2. Group B: (20 patients) will receive pregabalin oral therapy (50mg after each dialysis session) for 2 months.

Timeline

Start
2021-08-01
Primary completion
2022-03-01
Completion
2022-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 50 mg Oral

Indications

No indication recorded.